» Articles » PMID: 20090396

An Open Randomized Comparison of Clinical Effectiveness of Protocol-driven Opioid Analgesia, Celiac Plexus Block or Thoracoscopic Splanchnicectomy for Pain Management in Patients with Pancreatic and Other Abdominal Malignancies

Overview
Journal Pancreatology
Date 2010 Jan 22
PMID 20090396
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: In inoperable malignancy, pain relief with opioids is often inadequate. Nerve block procedures may improve symptom control. Our aim was to assess celiac plexus block (CPB) and thoracoscopic splanchnicectomy (TS) in patients receiving appropriate medical management (MM).

Methods: Patients with confirmed irresectable malignancy of the pancreas or upper abdominal viscera who required opioid analgesia were randomized to MM alone, MM+CPB, or MM+TS. Randomization was stratified by treatment centre, tumour type and previous opioid medication. The primary endpoint was pain relief at 2 months.

Results: 65 patients (58 pancreas cancer) were randomized, 18 withdrew or died within 2 months. Effective pain relief was achieved in only one third of subjects at 2 weeks, and just under half at 2 months (MM: 6/19 and 5/12 evaluable patients; CPB: 5/14 and 5/9; TS 4/14 and 4/11). There were no significant differences between the groups in pain scores or opioid consumption, and there was no correlation between continued use of opioids and effective pain relief.

Discussion: Previous randomized studies have shown small differences in pain scores, but no difference in opioid consumption and quality of life. The absence of any benefit from interventions in the present study questions their value.

Citing Articles

Sympathetic nerve blocks for persistent pain in adults with inoperable abdominopelvic cancer.

Nagar S, Nagar S, Jordan V, Dawson J Cochrane Database Syst Rev. 2024; 6:CD015229.

PMID: 38842054 PMC: 11154857. DOI: 10.1002/14651858.CD015229.pub2.


Efficacy and Safety of Celiac Plexus Neurolysis in the Treatment of Chronic Pain Secondary to Oncological Pathology of the Upper Hemiabdomen: A Systematic Review and Meta-Analysis.

Pacheco-Feijoo G, Amado-Tineo J, Plancarte-Sanchez R, Valdivia C, Lopez-Millan J Indian J Palliat Care. 2023; 29(4):394-406.

PMID: 38058484 PMC: 10696325. DOI: 10.25259/IJPC_203_2022.


Percutaneous splanchnic nerve neurolysis analgesic efficacy and safety for cancer-related pain: a systematic review and meta-analysis.

Matsumoto T, Yoshimatsu R, Osaki M, Miyatake K, Kitaoka N, Baba Y Support Care Cancer. 2023; 31(6):324.

PMID: 37148332 DOI: 10.1007/s00520-023-07746-y.


Celiac plexus neurolysis for abdominal cancers: going beyond pancreatic cancer pain.

Ambai V, Singh V, Boorman D, Neufeld N Pain Rep. 2021; 6(1):e930.

PMID: 34712884 PMC: 8546843. DOI: 10.1097/PR9.0000000000000930.


Pancreas Cancer-Associated Pain Management.

Coveler A, Mizrahi J, Eastman B, Apisarnthanarax S, Dalal S, McNearney T Oncologist. 2021; 26(6):e971-e982.

PMID: 33885205 PMC: 8176967. DOI: 10.1002/onco.13796.